TARGET MARKET DETERMINATION MADE BY: RADIOPHARM THERANOSTICS LIMITED (ACN 647 877 889) of Suite 1, Level 3, 62 Lygon Street, Carlton South, VIC 3053 ( Company ) PRODUCT: Subject to shareholder approval, free attaching options ( Attaching Options ) in connection with an offer of shares...
Target market determination (TMD)
Filed with ASX ·
6ix hasn’t read this filing yet.
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Prospectus
- Notice Under Section 708A
- Application for quotation of securities - RAD
- Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up to Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
- RAD completes A$12.5 M placement and launches A$6 M SPP
Later from Radiopharm Theranostics
- Change in substantial holding
- Quarterly Activities/Appendix 4C Cash Flow Report
- Update - Proposed issue of securities - RAD
- Share Purchase Plan - Now Open
- Notice of Extraordinary General Meeting and Proxy Form
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics